Improved cardiorespiratory fitness helps lower dementia risk: study
By
Alicia Lasek
Nov 12, 2019
Improving cardiorespiratory fitness over time halves dementia risk in older adults, a unique health survey analysis has found.
Coffee drinkers have reduced risk of common liver cancer: study
By
Alicia Lasek
Nov 09, 2019
Middle-aged coffee drinkers have half the odds of developing a common liver cancer than their peers who don’t partake, say researchers.
High-intensity exercise can help jog memory
By
Alicia Lasek
Nov 02, 2019
High-intensity exercise may be the best option for quickly boosting memory capacity in late life, say Canadian researchers.
Dementia unlikely for those who get past these hurdles, study finds
By
Alicia Lasek
Nov 02, 2019
A brief cognitive screening combined with an olfactory test may rule out future dementia in people with mild cognitive impairment, say researchers.
African Americans more likely to be discharged to a skilled care facility after knee replacement
By
Alicia Lasek
Oct 31, 2019
African American patients are up to five times more likely than white patients to be discharged to an SNF after knee replacement, rather than to their home.
Machine learning tracks tremor severity over time in Parkinson’s
By
Alicia Lasek
Oct 30, 2019
Wearable devices that use machine learning can accurately detect and rate Parkinson’s disease tremors outside the clinical setting.
Bracelet may help predict dementia-related agitation
By
Alicia Lasek
Oct 26, 2019
A location-monitoring bracelet developer has received an NIH grant to study whether its device can detect agitation in seniors with dementia.
Palliative care tool helps foster end-of-life conversations
By
Alicia Lasek
Oct 23, 2019
A new palliative care tool can help clinicians provide contextual medical advice and caregivers engage in end-of-life conversations.
Mobility promotion efforts needed across the globe, group insists
By
Alicia Lasek
Oct 22, 2019
There is an urgent need to maintain mobility in the world’s older population. So states a new international report, released this weekend.
Expanded Xofluza approval includes seniors at risk of flu complications
By
Alicia Lasek
Oct 20, 2019
The U.S. Food & Drug Administration has expanded approval of the oral antiviral drug Xofluza for people at high risk of flu complications.